Search Results - "Cole, John T"

Primary colon adenocarcinoma with choriocarcinoma differentiation: a case report and review of the literature by Boyce, Jessica, Tawagi, Karine, Cole, John T

“…Choriocarcinoma is an aggressive malignancy of trophoblastic tissue, typically of gestational etiology. Sporadic, nongestational cases are rarely found outside…”
Get full text

Endocrine Therapy for Early Breast Cancer: Updated Review by Tremont, Alexander, Lu, Jonathan, Cole, John T

“…Although breast cancer is still the second most common cause of cancer-related deaths, breast cancer mortality has been declining because of advances in the…”
Get full text

A phase III study of radiation therapy plus carmustine with or without recombinant interferon‐α in the treatment of patients with newly diagnosed high‐grade glioma by Buckner, Jan C., Schomberg, Paula J., McGinnis, William L., Cascino, Terrence L., Scheithauer, Bernd W., O'Fallon, Judith R., Morton, Roscoe F., Kuross, Steven A., Mailliard, James A., Hatfield, Alan K., Cole, John T., Steen, Preston D., Bernath, Albert M.

“…BACKGROUND The current study was conducted to determine whether the addition of interferon‐α (IFN‐α) to treatment with radiation therapy and carmustine (BCNU)…”
Get full text

Factors influencing the initiation of adjuvant endocrine therapy in patients with Estrogen receptor-positive ductal carcinoma in situ: A single institution experience by Farag, Fady, Levy, Julia, Cole, John T.

“…e18569 Background: Ductal carcinoma in situ (DCIS) is a non-obligate precursor to invasive ductal breast cancers. The aim of treatment in DCIS is to prevent…”
Get full text

Chicken sarcoma to human cancers: a lesson in molecular therapeutics by Prakash, Om, Bardot, Stephen F, Cole, John T

“…Inhibition of Lyn activity using a sequence-based Lyn inhibitor peptide decreases proliferation of hormone refractory prostate cancer cell lines and…”
Get full text

A phase II trial of docetaxel and carboplatin as first-line chemotherapy for metastatic breast cancer: NCCTG study N9932 by Perez, Edith A, Suman, Vera J, Fitch, Tom R, Mailliard, James A, Ingle, James N, Cole, John T, Veeder, Michael H, Flynn, Patrick J, Walsh, Daniel J, Addo, Ferdinand K

“…A phase II multi-institutional clinical trial conducted to evaluate the efficacy and tolerability of docetaxel and carboplatin as first-line therapy for women…”
Get more information

COVID-19 in Relation to Hematological Events (Thrombosis/Bleeding) and Mortality in Inpatient Setting by Gadde, Saikrishna, Manjunath, Nikhil, Badari, Ambuga, Cole, John T., Saeed, Rula

“…COVID-19 is a newly diagnosed entity that has been identified for about 6 months. With the US now being the prevalent nation affected, we aimed to identify…”
Get full text

Randomized phase III trial of eribulin (E) versus standard weekly paclitaxel (P) as first- or second-line therapy for locally recurrent or metastatic breast cancer (MBC) by Liu, Minetta C., Hillman, David W., Frith, Ashley Elizabeth, Lyss, Alan P., Weckstein, Douglas Jay, Moreno-Aspitia, Alvaro, Le-Lindqwister, Nguyet, Isaacs, Claudine, Wender, Donald B., Lewis, DeQuincy Andrew, Cole, John T., Jaslowski, Anthony John, Rowland, Kendrith M., Openshaw, Thomas H., Friday, Bret Edward Buckley, Fleming, Gini F., Asmus, Erik, Rogak, Lauren J., Basch, Ethan M., Dueck, Amylou C.

“…Abstract only 1016 Background: The ph III EMBRACE trial of E vs physician’s choice of tx led to FDA approval of E as ≥3rd-line tx for MBC pts with prior…”
Get full text

Recent advances in the systemic therapy of breast cancer by Cole, J T

“…A number of advances have been made over the last decade in the systemic therapy of breast cancer, including 1) the introduction of the taxanes, paclitaxel and…”
Get full text

In-vitro synergistic cellular proliferation inhibition in pancreatic cancer cells Su86 and Mia-PaCa-2 with fluvastatin and nab-paclitaxel by Feinsilber, Doron, Whatcott, Cliff, Matrana, Marc Ryan, Fuloria, Jyotsna, Satti, Suma, Cole, John T., Luo, Qingyang, Munoz, Ruben

“…Abstract only…”
Get full text

In vitro synergistic cellular proliferation inhibition in pancreatic cancer cells Su86 and Mia-PaCa-2 with fluvastatin and nab-paclitaxel by Feinsilber, Doron, Whatcott, Cliff, Matrana, Marc Ryan, Cole, John T., Munoz, Ruben, Luo, Qingyang, Fuloria, Jyotsna, Satti, Suma

“…Abstract only 331 Background: Statins have been shown to possess antiproliferative activity in-vitro. Synergism with multiple drug combinations has been of…”
Get full text

Abstract 1477: Circulating miR-125a-3p and miR-451a may be liquid biopsy biomarkers for the diagnosis of breast cancer by Yousefi, Hassan, Eastlack, Steven C., Fong, Jordyn T, Okpechi, Samuel C., Zabaleta, Jovanny, Buckner, Lyndsey R., Trapani, Donnalee N, Sims, Erin, McDaniel, Alison McDaniel, Scuderi, Heather, Lakey, Meredith A., Cole, John T., Alahari, Suresh K.

“…Abstract Background: Breast cancer is the most prevalent female cancer. Emerging evidence suggests that the unique serum miRNAs can assist in the early…”
Get full text

Can breast cancer be prevented? by Kardinal, C G, Cole, J T

“…Breast cancer is the most common invasive cancer in American women and is second only to carcinoma of the lung in cancer deaths. The results of the National…”
Get full text

L-arginine depletion by PEG-arginase I, a new potential therapy for acute lymphoblastic leukemia by Crombet Ramos, Ofelia, Hernandez, Claudia, Morrow, Kevin, Cole, John T., Rodriguez, Paulo

“…Abstract only 6580 Background: Advances in therapies have resulted in an overall complete remission rate of approximately 85% for childhood acute lymphoblastic…”
Get full text

Prelinical Evaluation of Lyn Kinase Inhibition for the Treatment of B Cell Chronic Lymphocytic Leukemia (B-CLL) by Velcheti, Vamsidhar, Li, Li, Philips, Joseph, Fuloria, Jyotsna, Rodwig, Francis R, Cole, John T., Samaniego, Felipe, Prakash, Om

“…Abstract 3447 Poster Board III-335 B-CLL is characterized by the accumulation of mature B lymphocytes incapable of undergoing apoptosis. Although several…”
Get full text

Protein Kinase C-Epsilon Is An Important Component of the Lyn Kinase Signaling Pathway in the Apoptotic Resistance of B- Chronic Lymphocytic Leukemia Cells by Velcheti, Vamsidhar, Tamma, Srikanth, Larned, Zoe L, Fuloria, Jyotsna, Li, Li, Rodwig, Francis R, Cole, John T., Samaniego, Felipe, Prakash, Om

“…Although several mechanisms of apoptotic defects have been implicated in B- chronic lymphocytic leukemia (CLL) cells, the exact signaling pathways underlying…”
Get full text

A randomized controlled trial of darbepoetin alfa administered as a fixed or weight‐based dose using a front‐loading schedule in patients with anemia who have nonmyeloid malignancies by Hesketh, Paul J., Arena, Francis, Patel, Dhimant, Austin, Matt, D'Avirro, Paul, Rossi, Gregory, Colowick, Alan, Schwartzberg, Lee

“…BACKGROUND The effect of using fixed versus weight‐based doses for erythropoietic agents has not been reported previously. To investigate this issue, the…”
Get full text

Is Terminology Enough by Cole, John T., Tulisano, Richard

Get full text

Acute myelomonocytic leukemia presenting as a benign-appearing cutaneous eruption by Horlick, H P, Silvers, D N, Knobler, E H, Cole, J T

“…Aleukemic leukemia cutis is a rare condition in which patients have skin lesions containing leukemic cells before evidence of leukemia can be detected in the…”
Get more information

A phase III study of radiation therapy plus carmustine with or without recombinant interferon-? in the treatment of patients with newly diagnosed high-grade glioma by Buckner, Jan C., Schomberg, Paula J., McGinnis, William L., Cascino, Terrence L., Scheithauer, Bernd W., O'Fallon, Judith R., Morton, Roscoe F., Kuross, Steven A., Mailliard, James A., Hatfield, Alan K., Cole, John T., Steen, Preston D., Bernath, Albert M.

Get full text